Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
InstaDosis is a mobile medication-assistance app for healthcare professionals, positioned as a tool for “instant drug dose calculation.” The page says it is available on Google Play and the App Store, and highlights a “professional drug compendium for the Panama market.” Based on the page content, it looks more like a dosage verification and risk-alert tool used before clinical prescribing, rather than a clearly defined generative AI product.
The app workflow is fairly straightforward: users first adjust the patient’s weight and age, then enable medical conditions such as renal impairment or pregnancy, and then add the drugs to be prescribed or analyzed. The system uses colored icons to display drug interactions and alerts. It also supports adding pathological conditions such as diabetes, hypertension, and angina, and analyzes how these underlying diseases may affect medication risk. In addition, the app provides drug fault alerts and warnings about interactions between medications and alcoholic beverages.
The page does not state that it uses AI models, machine learning, or large language models, nor does it disclose the data sources, medical review process, or algorithmic rules behind its dose calculations and interaction checks. Therefore, it should not be classified as an AI diagnostic or treatment tool. The quality of its output mainly depends on the coverage of its drug database, the accuracy of its rules, and how frequently it is updated, but the page does not provide these key details. Another limitation is that its drug compendium is specifically designed for the Panama market, so support for drug names, formulations, and clinical guidelines in other countries may be limited.
The page mentions beta access, free registration on Android, and a free trial, but it does not provide paid plans, pricing, trial duration, the boundaries of free features, or payment methods. Capabilities such as APIs, electronic medical record integration, and data export are also not mentioned. On privacy, the page does not explain whether patient information is processed locally, whether it is stored with encryption, or whether it meets healthcare data compliance requirements.
Its strengths are that its use case is close to prescription decision-making, its inputs are simple, and it covers risk factors such as age, weight, special medical conditions, comorbidities, and alcohol interactions. Its weaknesses are the lack of public information, especially around medical evidence, privacy policy, pricing, and support services. It is better suited to doctors, pharmacists, and clinical staff in Panama, or those using the local drug database, as an auxiliary checking tool. It should not be used as a replacement for professional medical judgment.
Access from mainland China, app store availability, network connectivity, and payment methods are not explained in the page content, so they should be considered unknown. Chinese users who need a local drug database and Chinese-language support may consider 用药助手, related tools from 丁香园, or international alternatives such as Epocrates, Medscape, Drugs.com, Lexicomp, and Micromedex.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on instadosis.com official site.
instadosis.com is an Panama AI Apps provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach instadosis.com directly.